CIK 0001822791 · Non-accelerated filer<br>Smaller reporting company
Clene Inc.
Sign in to watch- Ticker
- CLNN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 852828339
- Phone
- 801-676-9695
- Business address
- 6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY, UT, 84121
- Former names
- Chelsea Worldwide Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Material agreement · Results of operations
- 10-Q Report Quarterly Report
- 4 Open-market sale 10% owner sold 95,473 shares at an average $6.33 ($604,130)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 144 Insider Sale of Securities
- 4 Open-market sale 10% owner sold 78,679 shares at an average $6.74 ($530,439)
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure · Other events
- 4 Open-market sale 10% owner sold 19,497 shares at an average $5.78 ($112,779)
- 144 Insider Sale of Securities
- 4 Open-market sale 10% owner sold 65,663 shares at an average $6.14 ($403,084)
- 4 Open-market sale 10% owner sold 39,162 shares at an average $6.43 ($251,898)
Page 3 of 36 · 707 filings